OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Comorbidity in gout and hyperuricemia: prevalence, causes, prospects of urate lowering therapy
М. С. Елисеев, A. M. Novikova
Terapevticheskii arkhiv (2019) Vol. 91, Iss. 5, pp. 120-128
Open Access | Times Cited: 18
М. С. Елисеев, A. M. Novikova
Terapevticheskii arkhiv (2019) Vol. 91, Iss. 5, pp. 120-128
Open Access | Times Cited: 18
Showing 18 citing articles:
A comprehensive analysis of trends in the burden of gout in China and globally from 1990 to 2021
Shiwei Xie, Heng Xiao, Lei Xu, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Shiwei Xie, Heng Xiao, Lei Xu, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Burden of gout among different WHO regions, 1990–2019: estimates from the global burden of disease study
Shoheera Punjwani, Chinmay Jani, Weitao Liu, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 7
Shoheera Punjwani, Chinmay Jani, Weitao Liu, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 7
The association of visceral fat metabolism score with hyperuricemia—evidence from NHANES 1999–2018
Lin Xie, Haiyan Qu, Dandan Lai, et al.
Frontiers in Nutrition (2025) Vol. 11
Open Access
Lin Xie, Haiyan Qu, Dandan Lai, et al.
Frontiers in Nutrition (2025) Vol. 11
Open Access
Treatment and diagnostics of gout: Unsolved problems in clinical practice
М. С. Елисеев, Е. Л. Насонов
Rheumatology Science and Practice (2024) Vol. 62, Iss. 1, pp. 7-12
Open Access | Times Cited: 1
М. С. Елисеев, Е. Л. Насонов
Rheumatology Science and Practice (2024) Vol. 62, Iss. 1, pp. 7-12
Open Access | Times Cited: 1
Rational use of recommendations for urate-lowering therapy: clinical examples
М. С. Елисеев, О. V. Zhelyabina
Modern Rheumatology Journal (2022) Vol. 16, Iss. 3, pp. 85-90
Open Access | Times Cited: 6
М. С. Елисеев, О. V. Zhelyabina
Modern Rheumatology Journal (2022) Vol. 16, Iss. 3, pp. 85-90
Open Access | Times Cited: 6
Polymorphism in folate cycle genes in patients with gout in the Russian population of Trans-Baikal Territory
N. N. Kushnarenko, M. Yu. Mishko, Т. А. Медведева
The Siberian Journal of Clinical and Experimental Medicine (2020) Vol. 35, Iss. 1, pp. 142-150
Open Access | Times Cited: 4
N. N. Kushnarenko, M. Yu. Mishko, Т. А. Медведева
The Siberian Journal of Clinical and Experimental Medicine (2020) Vol. 35, Iss. 1, pp. 142-150
Open Access | Times Cited: 4
Cardiovascular and metabolic comorbidities associated with rheumatic diseases: focus on hyperuricemia and gout
А. Р. Бабаева, Е. В. Калинина, M.S. Zvonorenk, et al.
Russian Medical Inquiry (2023) Vol. 7, Iss. 3, pp. 150-159
Open Access | Times Cited: 1
А. Р. Бабаева, Е. В. Калинина, M.S. Zvonorenk, et al.
Russian Medical Inquiry (2023) Vol. 7, Iss. 3, pp. 150-159
Open Access | Times Cited: 1
Prospects for prescription of urate-lowering therapy in patients with asymptomatic hyperuricemia and gout
E. V. Panina, М. С. Елисеев
Meditsinskiy sovet = Medical Council (2023), Iss. 21, pp. 128-134
Open Access | Times Cited: 1
E. V. Panina, М. С. Елисеев
Meditsinskiy sovet = Medical Council (2023), Iss. 21, pp. 128-134
Open Access | Times Cited: 1
Mechanisms of cartilage damage in gout and hyperuricemia
E. V. Panina
Rheumatology Science and Practice (2024) Vol. 62, Iss. 2, pp. 162-167
Open Access
E. V. Panina
Rheumatology Science and Practice (2024) Vol. 62, Iss. 2, pp. 162-167
Open Access
Hypertension and asymptomatic hyperuricemia: algorithm of diagnostics and management (literature review)
Н. А. Козиолова, A. I. Chernyavina
Arterial’naya Gipertenziya (Arterial Hypertension) (2022) Vol. 28, Iss. 4, pp. 316-327
Open Access | Times Cited: 1
Н. А. Козиолова, A. I. Chernyavina
Arterial’naya Gipertenziya (Arterial Hypertension) (2022) Vol. 28, Iss. 4, pp. 316-327
Open Access | Times Cited: 1
Microbiota as a new pathogenetic factor in the development of chronic hyperuricemia and gout. Part 2: gout therapy and the gut microbiota
М. С. Елисеев, E. N. Kharlamova, О. V. Zhelyabina, et al.
Modern Rheumatology Journal (2022) Vol. 16, Iss. 6, pp. 7-11
Open Access | Times Cited: 1
М. С. Елисеев, E. N. Kharlamova, О. V. Zhelyabina, et al.
Modern Rheumatology Journal (2022) Vol. 16, Iss. 6, pp. 7-11
Open Access | Times Cited: 1
Clinical significance of 24-hour blood pressure monitoring in prediction of hypertension development in patients with gout
M. V. Gubanova, N. N. Kushnarenko, Т. М. Караваева
Siberian Journal of Clinical and Experimental Medicine (2021) Vol. 36, Iss. 3, pp. 104-110
Open Access | Times Cited: 1
M. V. Gubanova, N. N. Kushnarenko, Т. М. Караваева
Siberian Journal of Clinical and Experimental Medicine (2021) Vol. 36, Iss. 3, pp. 104-110
Open Access | Times Cited: 1
Principles of urate-lowering therapy: eight steps to success
О. V. Zhelyabina, М. С. Елисеев, А. М. Лила
Modern Rheumatology Journal (2023) Vol. 17, Iss. 3, pp. 104-110
Open Access
О. V. Zhelyabina, М. С. Елисеев, А. М. Лила
Modern Rheumatology Journal (2023) Vol. 17, Iss. 3, pp. 104-110
Open Access
Comparison of colorimetric and electrochemical (Easy Touch GCU Meter) methods for determination of blood uric acid in clinical practice in patients with gout and hyperuricemia (data from a pilot study)
М. С. Елисеев, E. V. Panina, O. V. Zheliabina
Modern Rheumatology Journal (2023) Vol. 17, Iss. 5, pp. 87-91
Open Access
М. С. Елисеев, E. V. Panina, O. V. Zheliabina
Modern Rheumatology Journal (2023) Vol. 17, Iss. 5, pp. 87-91
Open Access
THROMBOEMBOLIC RISK FACTORS IN DIALYSIS PATIENTS WITH END-STAGE CHRONIC KIDNEY DISEASE AND NON-VALVULAR ATRIAL FIBRILLATION BY CHA2 DS2 -VASc AND D-DIMER LEVEL
YURIY L. KETSKO, А. В. Жестков, GALINA A. SUKACH, et al.
The Bulletin of Contemporary Clinical Medicine (2023) Vol. 16, Iss. 5, pp. 120-126
Open Access
YURIY L. KETSKO, А. В. Жестков, GALINA A. SUKACH, et al.
The Bulletin of Contemporary Clinical Medicine (2023) Vol. 16, Iss. 5, pp. 120-126
Open Access
Uric acid as one of the markers of polymorbidity in patients with coronary heart disease
E. V. Sevostyanova, Yu. A. Nikolaev, И. М. Митрофанов, et al.
Russian Journal of Preventive Medicine (2022) Vol. 25, Iss. 1, pp. 71-71
Closed Access
E. V. Sevostyanova, Yu. A. Nikolaev, И. М. Митрофанов, et al.
Russian Journal of Preventive Medicine (2022) Vol. 25, Iss. 1, pp. 71-71
Closed Access
Hyperuricemia and its clinical significance
F. Karabaeva
Clinical Medicine and Pharmacology (2022) Vol. 8, Iss. 2, pp. 14-20
Closed Access
F. Karabaeva
Clinical Medicine and Pharmacology (2022) Vol. 8, Iss. 2, pp. 14-20
Closed Access
Hyperuricemia as a component of metabolic syndrome and a risk factor for comorbid conditions
F. Karabaeva, Elena Belyaeva
Clinical Medicine and Pharmacology (2022) Vol. 8, Iss. 3, pp. 19-28
Closed Access
F. Karabaeva, Elena Belyaeva
Clinical Medicine and Pharmacology (2022) Vol. 8, Iss. 3, pp. 19-28
Closed Access
